• AICAR and AMPK: Strategic AMPK Activation in Translational R

  2026-06-13

  This thought-leadership article explores how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside), a potent cell-permeable AMPK activator, provides translational researchers with mechanistic leverage to dissect and therapeutically modulate metabolic stress, inflammation, and mitochondrial dysfunction. Bridging breakthroughs in sarcopenic obesity and mitophagy with practical experimental workflows, we chart a credible, evidence-backed path from bench to bedside for metabolic disease research. The article differentiates itself from standard product pages by offering deep mechanistic context, strategic protocol guidance, and a panoramic view on the future of AMPK-targeted interventions.

• Gramine Induces Ferroptosis in TNBC via CUL3-MTDH Regulation

  2026-06-12

  This study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by triggering ferroptosis through modulation of the CUL3-MTDH axis. The findings uncover a novel regulatory mechanism for ferroptosis and highlight gramine's therapeutic promise against aggressive TNBC.

• Mc-Val-Cit-PABC-PNP: Technical Guidance for ADC Synthesis

  2026-06-12

  Mc-Val-Cit-PABC-PNP is a cathepsin B-cleavable ADC peptide linker designed for antibody-drug conjugate workflows that require selective lysosomal payload release. It is optimized for protocols using organic solvents and is unsuitable for applications needing water solubility or clinical/diagnostic use.

• hly Gene Deletion Reduces Biofilm and Antibiotic Resistance

  2026-06-11

  The referenced study demonstrates that deletion of the hly gene in Listeria monocytogenes significantly impairs biofilm formation and increases susceptibility to ribosome-targeting antibiotics. This finding clarifies hly’s regulatory role in biofilm development and antibiotic resistance, suggesting new avenues for controlling Listeria persistence in food environments.

• Amitriptyline HCl: Protocol Parameters and Lab Workflow Guid

  2026-06-11

  Amitriptyline HCl (SKU B2231) is a validated, high-purity tool for studying neurotransmitter receptor modulation in neuropharmacology and mood disorder research. It is optimized for CNS-targeted assays requiring strict solubility, handling, and QC protocols. This compound is not recommended for workflows needing long-term solution storage or applications outside neuropharmacological research.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-06-10

  Satir et al. (2020) demonstrated that moderate inhibition of BACE1, and thus reduction of amyloid-β production by up to 50%, does not impair synaptic transmission in primary neurons. This finding supports the feasibility of partial BACE1 inhibition as a safer therapeutic approach in Alzheimer’s disease research.

• Tiamulin (Thiamutilin): Dual-Action Veterinary Antibiotic In

  2026-06-10

  Tiamulin (Thiamutilin) is a pleuromutilin antibiotic and anti-inflammatory agent with proven efficacy in veterinary medicine. Its mechanism involves selective inhibition of bacterial protein synthesis and modulation of inflammatory signaling. This article details its molecular action, usage benchmarks, and regulatory guidance based on peer-reviewed data.

• Danazol in Bench Research: Applied Protocols & Troubleshooti

  2026-06-09

  Danazol (Danocrine) is a versatile tool for modeling steroidogenesis inhibition and modulating the hypothalamic–pituitary–gonadal axis. This article delivers actionable workflows, protocol refinements, and troubleshooting strategies tailored for endocrine and oncology research, leveraging APExBIO’s high-purity Danazol.

• Z-LEHD-FMK: Strategic Caspase-9 Inhibition for Translational

  2026-06-09

  Explore how Z-LEHD-FMK, a selective irreversible caspase-9 inhibitor, advances translational research through mechanistic insight and protocol innovation. This article bridges mitochondrial apoptosis biology and real-world assay design, integrating evidence from myocardial ischemia/reperfusion models to guide next-generation workflows in cancer and neuroprotection studies.

• Nintedanib (BIBF 1120): Advanced Insights into ATRX-Linked T

  2026-06-08

  Explore how Nintedanib (BIBF 1120) enables precision oncology by exploiting ATRX-deficiency in high-grade glioma and other tumors. This article delivers a deep dive into mechanistic, protocol, and translational considerations beyond standard assay workflows.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) Gu

  2026-06-08

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide high-specificity capture of biotinylated molecules for applications such as protein purification, immunoprecipitation, and nucleic acid isolation. This product is best suited for workflows requiring rapid, low-background separation and is not recommended for protocols incompatible with streptavidin-biotin binding or requiring beads outside the 3 μm size range.

• Electrostatic Partitioning in α-Synuclein Condensates Shapes

  2026-06-07

  This study reveals that α-synuclein condensates formed via liquid–liquid phase separation exhibit a strongly negative electrostatic potential, which governs selective partitioning of proteins and small molecules. The findings highlight electrostatic modulation as a key determinant in biomolecular condensate organization and suggest new strategies for probing these structures in neurodegenerative disease research.

• Bismuth Subsalicylate: Molecular Insights Into GI Research T

  2026-06-06

  Explore the molecular mechanisms and advanced assay applications of Bismuth Subsalicylate in gastrointestinal disorder research. This in-depth analysis reveals how 1,3,2λ2-benzodioxabismin-4-one advances experimental precision beyond standard anti-inflammatory options.

• Nintedanib (BIBF 1120): Applied Protocols for Cancer Researc

  2026-06-05

  Nintedanib (BIBF 1120) empowers researchers with precise angiogenesis inhibition and robust antifibrotic activity, now leveraged for advanced tumor modeling and ATRX-deficient cancer studies. This article delivers actionable experimental workflows, troubleshooting guidance, and the latest translational insights for deploying Nintedanib in cutting-edge oncology and fibrosis research.

• IL-17A as a Prognostic Biomarker in GBS-Colonized Pregnancie

  2026-06-05

  This study identifies maternal IL-17A levels as a potential biomarker for predicting neonatal risk in pregnancies complicated by Group B Streptococcus (GBS) colonization. The findings reveal that impaired TLR1/2-driven cytokine responses, particularly reduced IL-17A, are associated with vertical transmission and invasive neonatal disease, highlighting avenues for improved risk stratification.

16108 records 1/1074 page Next 12345 下5页 Last page